Orgenesis Inc.
ORGSDelisted May 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001460602
Orgenesis Inc. was delisted on May 8, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 1 institution reported holding it in 13F filings for Q1 2025, worth $124.0K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Orgenesis Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 22 | 23 | +1 |
| Shares | 2.92M | 2.92M | +3.91K (+0.1%) |
| Value | $7.07M | $4.15M | −$2.92M (−41.3%) |
New holders (3)
Institutions that held Orgenesis Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 29,269 | $42.0K | 0.00% |
| Prudential Financial Inc | 19,350 | $27.0K | 0.00% |
| Royal Bank of Canada | 165 | $0 | 0.00% |
Sold out (2)
Institutions that held Orgenesis Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| D. E. Shaw & Co., Inc. | 25,053 | $61.0K |
| Kennedy Capital Management, Inc. | 15,166 | $37.0K |